Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 2
1966 5
1967 12
1968 8
1969 11
1970 8
1971 16
1972 8
1973 14
1974 11
1975 13
1976 7
1977 6
1978 10
1979 12
1980 16
1981 11
1982 15
1983 17
1984 16
1985 14
1986 10
1987 14
1988 11
1989 11
1990 18
1991 17
1992 9
1993 6
1994 9
1995 16
1996 7
1997 14
1998 9
1999 12
2000 15
2001 9
2002 12
2003 15
2004 11
2005 18
2006 14
2007 27
2008 15
2009 17
2010 21
2011 25
2012 17
2013 22
2014 37
2015 29
2016 25
2017 24
2018 23
2019 28
2020 18
2021 20
2022 19
2023 9
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

831 results

Results by year

Filters applied: . Clear all
Page 1
Spanish consensus on the prevention and treatment of Pseudomonas aeruginosa bronchial infections in cystic fibrosis patients.
Cantón R, Máiz L, Escribano A, Olveira C, Oliver A, Asensio O, Gartner S, Roma E, Quintana-Gallego E, Salcedo A, Girón R, Barrio MI, Pastor MD, Prados C, Martínez-Martínez MT, Barberán J, Castón JJ, Martínez-Martínez L, Poveda JL, Vázquez C, de Gracia J, Solé A; en representación del Grupo Español de Consenso del Tratamiento Antimicrobiano en el Paciente con Fibrosis Quística. Cantón R, et al. Arch Bronconeumol. 2015 Mar;51(3):140-50. doi: 10.1016/j.arbres.2014.09.021. Epub 2015 Jan 20. Arch Bronconeumol. 2015. PMID: 25614377 English, Spanish.
Cystic Fibrosis Foundation pulmonary guideline. pharmacologic approaches to prevention and eradication of initial Pseudomonas aeruginosa infection.
Mogayzel PJ Jr, Naureckas ET, Robinson KA, Brady C, Guill M, Lahiri T, Lubsch L, Matsui J, Oermann CM, Ratjen F, Rosenfeld M, Simon RH, Hazle L, Sabadosa K, Marshall BC; Cystic Fibrosis Foundation Pulmonary Clinical Practice Guidelines Committee. Mogayzel PJ Jr, et al. Ann Am Thorac Soc. 2014 Dec;11(10):1640-50. doi: 10.1513/AnnalsATS.201404-166OC. Ann Am Thorac Soc. 2014. PMID: 25549030 Review.
Do Contact Precautions Reduce the Incidence of Intensive Care Unit-Acquired Pseudomonas aeruginosa Infections? The DPCPYO (Detection and Contact Precautions for Patients With P. aeruginosa) Cluster-Randomized Crossover Trial.
Slekovec C, Robert J, Berthelot P, van der Mee-Marquet N, Rogues AM, Derouin V, Cholley P, Bertrand X, Gbaguidi-Haore H; DPCPYO Trial Group. Slekovec C, et al. Clin Infect Dis. 2021 Nov 2;73(9):e2781-e2788. doi: 10.1093/cid/ciaa1663. Clin Infect Dis. 2021. PMID: 33137174 Clinical Trial.
831 results